We included peptides specific for surface receptors known to be expressed on RMS cells (NCAM-1, EGFR, CB1, TFR1, and uPAR; see Supplementary Table S2 for an overview of the literature), or reported to successfully target other tumors, tumor blood vessels, or tumor lymphatic vessels (Nucleolin, CD13, p32). This evidence concerns the gene CNR1 and neoplasm.